BRCA1 phosphorylation: Biological consequences

Cancer Biology and Therapy

Volumn 5, Issue 5, 2006, Pages 470-475

  Ouchi, Toru ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

BRCA1; Cell cycle; Checkpoint; DNA damage; Phosphorylation

Indexed keywords

ATM PROTEIN; ATR PROTEIN; AURORA A KINASE; BRCA1 PROTEIN; CASPASE 3; CHECKPOINT KINASE 2; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; DNA; DNA PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

CELL CULTURE; CELL CYCLE PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; DNA DAMAGE; ENZYME ACTIVATION; GENE ISOLATION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; NONHUMAN; ONCOGENE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION;

EID: 33646869228     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.5.2845     Document Type: Review

References (80)

1. Miki Y, Swensen J, Shuattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McCure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Nauhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
2. Chen A, Kleiman FE, Manley JL, Ouchi T, Pan ZQ. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase. J Biol Chem 2002; 277:22085-92.
3. Manke IA, Lowery DM, Nguyen A, Yaffe MB. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 2003; 302:636-9.
4. Yu X, Chini CC, He M, Merg G, Chen J. The BRCT domain is a phospho-protein binding domain. Science 2003; 302:639-42.
5. Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci USA 1997; 94:7138-43.
6. Cobrinick D, Dowdy SF, Hinds PW, Mittnacht S, Weinberg RA. The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 1992; 17:312-5.
7. Hollingworth RE Jr, Hensey CE, Lee WH. Curr Opin Genet Dev 1993; 3:55-62.
8. Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 1996; 56:3168-72.
9. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90:425-35.
10. Okada S, Ouchi T. Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affects its subcellular localization. J Biol Chem 2003; 278:2015-20.
11. Ruffener H, Jiang W, Craig AG, Hunter T, Verma IM. BRCA1 is phosphorylated at Serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation sites. Mol Cell Biol 1999; 19:4843-54.
12. Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM. CBP/p300 interact with and function as a transcriptional coactivator of BRCA1. Proc Natl Acad Sci USA 2000; 97:1020-5.
13. Burden S, Yarden Y. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 1997; 18:847-55.
14. Altiok N, Altiok S, Changeux JP. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity. EMBO J 1997; 16:717-25.
15. Altiok S, Batt D, Altiok N, Papautsky A, Downward J, Roberts TM, Avraham H. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-kinase/Akt in breast cancer cells. J Biol Chem 1999; 274:32274-8.
16. Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH. The nuclear localization sequences of the BRCA1 protein interact with the importin-± subunit of the nuclear transport signal receptor. J Biol Chem 1996; 271:32863-8.
17. Miralem T, Avraham HK. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus. Mol Cell Biol 2003; 23:579-93.
18. Sciliciano JD, Canman CE, Taya Y, Sakaguchi E, Appella E, Kastan MB. DNA damage induces phosphorylation of the amino terminusof p53. Genes Dev 1997; 11:3471-81.
19. Canman CE, Wilff AC, Chen CY, Fornace AJ Jr, Kastan MB. The p53-dependent G1 cell cycle checkpoint pathway and ataxia telangiectasia. Cancer Res 1994; 54:5054-8.
20. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsk WV, Plinkett BS, Vogelstein B, Fornace AJ Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell 1992; 71:587-97.
21. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but gene apart. Annu Rev Genet 1997; 31:635-62.
22. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, Kastan MB. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. 2000; Nature 404:613-7.
23. Zhao S, Weng YC, Yuan SS, Lin YT, Hsu HC, Lin SC, Gerbino E, Song MH, Zdzienicka MZ, Gatti RA, Shay JW, Ziv Y, Shilok Y, Lee EY. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 2000; 405:473-7.
24. Cortez D, Wang Y, Qin J, Elledge SJ. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science 1999; 286:1162-6.
25. Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylatiton of BRCA1 at distinct and overlapping sites. J Biol Chem 2001; 276:17276-80.
26. Xu B, Kim ST, Kastan MB. Involvement of BRCA1 in S-phase and G2-phase checkpoints after ionizing radiaiotn. Mol Cell Biol 2001; 21:3445-50.
27. Xu B, O'Donnell AH, Kim ST, Kastan MB. Phosphorylation of serine 1387 in BRCA1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res 2002; 62:4588-91.
28. Canman CE, Lim for the Atm-mediated S-phase checkpoint after ionizing radiation. Cancer Res. 2002; 62: 4588
29. DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281:1677-9.
30. Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 1999; 274:37538-43.
31. Lakin ND, Hann BC, Jackson SP. The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. Oncogene 1999; 18:3989-95.
32. Tibbetts RS, Brumbaugh KB, Williums JW, Sarkaria JN, Cliby WA, Shiek SY, taya Y, Prives C, Abraham RT. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13:152-7.
33. Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL, Friend SH. Overexpression of a kinase-inactive ATR protein causes sensitivity too DNA-damaging agents and defects in cell cycle checkpoints. EMBO J 1998; 17:159-69.
34. Wright JA, Keegan KS, Heredeen DR, Bentley NJ, Carr AM, Hoekstra MF, Concannon P. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc Natl Acad Sci USA 1998; 95:7445-50.
35. Barlow C, Hirotsune S, Paylor R. Liyanaga M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A. Atm-deficient mice: A paradigm of ataxia talengiectasia. Cell 1996; 86:159-71.
36. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 1996; 10:2411-22.
37. Brown E, Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev 2000; 14:397-402.
38. de Klein A, Muijtjens M, van Os R, Verhoeven Y, Smit B, Carr AM, Lehmann AR, Hoeijmakers JH. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr Biol 2000; 10:479-82.
39. Chen J. Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage. Cancer Res 2000; 60:5037-9.
40. Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston DM, Elledge SJ, Abraham RT. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 2000; 14:2989-3002.
41. Banin S, Moyal L, Shieh SY, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281:1674-7.
42. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, garber JE, Haber DA. Heterogyzous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 1999; 286:2528-31.
43. Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T. Concomitant inactivation of p53 and chk2 in breast cancer. Oncogene 2002; 21:1316-24.
44. Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. HCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 2000; 404:201-4.
45. Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT, Chung JH, Powell SN, Xia F. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol 2004; 24:708-18.
46. Ban DT, Fu YP, Chen ST, Cheng TC, Yu JC, Wu PE, Shen CY. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res 2004; 64:5013-9.
47. Zhong Q, Chen CF, Chen PL, Lee WH. BRCA1 facilitates microhomology- mediated end joining of DNA double strand breaks. J Biol Chem 2002; 277:28641-7.
48. Baldeyron C, Jacquemin E, Smith J, Jacquemont C, De Oliveira I, Gad S, Feunteun J, Stoppa-Lyonnet D, Papadopoulo D. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene 2002; 21:1401-10.
49. Coupier I, Baldeyron C, Rousseau A, Mosseri V, Pages-Berhouet S, Caux-Moncoutier V, Papadopoulo D, Stoppa-Lyonnet D. Fidelity of DNA double-strand break repair in heterozygous cell lines harbouring BRCA1 missense mutations. Oncogene 2004; 23:914-9.
50. Moynahan ME, Chiu JW, Koller BH, Jasin M. BRCA! Controls homology-directed DNA repair. Mol Cell 1999; 4:511-8.
51. Snouwaert JN, Gowen LC, Latoour AM, Mohn AR, Xiao A, DiBiase L, Koller BH. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected bny expression of a brca1 transgene. Oncogene 1999; 18:7900-7.
52. Scully R, Ganesan S, Vlasakova K, Chen J, Socolovsky M, Livingston DM. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell 1999; 4:1093-9.
53. Wang H, Zeng ZC, Bui TA, DiBiase SJ, Qin W, Xia f, Powell SN, Iliakis G. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cell deficient in BRCA1 or BRCA2. Cancer Res 2001; 61:270-7.
54. Mak TW, Hakem A, McPherson JP, Shehabeldin A, Zablocki E, Mignon E, Duncan GS, Bouchard D, Wakeham A, Cheung A, Karaskova J, Sarosi I, Squire J, Marth J, Hakem R. Brca1 required for T cell lineage development but not for TCR loci rearrangement. Nat Immunol 2000; 1:77-82.
55. Zhong Q, Boyer TG, Chen PL, Lee WH. Deficient nonhomologous end-joining activity in cell-free extracts from BRCA1-null fibroblasts. Cancer Res 2002; 62:3966-70.
56. Merel P, Prieur A, Pfeiffer P, Delattre O, Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines. Oncogene 2002; 21:5654-9.
57. Wang HC, Chou WC, Shieh SY, Shen CY. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Cancer Res 2006; 66:1391-400.
58. Zhuang J, Zhang J, Willers H, Wang H, Chung JH, van Gent DC, Hallahan DE, Powell SN, Xia F. Checkpoint kinase 2-meediated phosphorylation of BRCA1 regulates the fidelity of nonhomologoous end-joining. Cancer Res 2006; 66:1401-8.
59. Kim SS, Cao L, Li C, Xu X, Huber LJ, Chodosh LA, Deng CX. Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a target mutation of the chk2 phosphorylation site in BRCA1. Mol Cell Biol 2004; 24:9498-507.
60. Xu X, Li C, Garrett-Beal L, Larson D, Wynshaw-Boris A, Deng CX. Direct removal of a floxed neo gene from a three-loxP conditional knockout allele by two novel approaches. Genesis 2001; 30:1-6.
61. Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX. Genetic interactions between tumor suppressors BRCA1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 2001; 28:266-71.
62. Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Chen L, Guan XY, Ried T. Deng CX. A target disruption of the murine BRCA1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 1998; 17:3115-24.
63. Liu CY, Flesken-Nikitin A, Li S, Zeng Y. Lee WH. Inactivation of the mouse BRCA1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 1996; 10:1835-43.
64. Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A. target mutations of breast cancer susceptibility gene homologs in mice: lethal phenotype of BRCA1, BRCA2, BRCA1/BRCA2, BRCA1/p53, and BRCA2/p53 nullizygous embryos. Genes Dev 1997; 11:1226-41.
65. Gowen LC, Joknson BL, Latour AM, Sulik KK, Koller BH. BRCA1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 1996; 12:191-4.
66. Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J, Mak TW. The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 1996; 85:1009-23.
67. Hohenstein P, Kielman MF, Breukel C, Bennett LM, Wiseman R, Krimpenfort P, Cornelisse C, van Ommen GJ, Devilee P, Fodde R. A targeted mouse BRCA1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality ay the headfold stage. Oncogene 2001; 20:2544-50.
68. Bischoff JR, Anderson L, Zku Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ, Plowman GD. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17:3052-65.
69. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkey BR, Sen S. Tumor amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20:189-93.
70. Marumoto T, Hirota T, Morisaki T, Kunitoku N, Zhang D, Ichikawa Y, Sasayama T, Kuninaka S, Mimori T, Tamaki N, Kimura M, Okano Y, Saya H. Roles of aurora-a kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cell 2002; 7:1173-82.
71. Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002; 21:483-92.
72. Aurora-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to taxol. Cancer Cell 2003; 3:51-62.
73. Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, Nitta M, Hatakeyama K, Saya H. Aurora-A and an interacting activator, the LIM protein ajuba, are required for mitotic commitment in human cells. Cell 2003; 278:51786-95.
74. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 1999; 3:389-95.
75. Hsu LC, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci USA 1998; 95:12983-8.
76. Hsu LC, Doan TP, White RL. Identification of a gamma-tubulin-bondong domain of BRCA1. Cancer Res 2001; 61:7713-8.
77. Ouchi M, Fujiuchi N, Sasai K, Katayama H, Minamishima YA, Ongusaha PP, Deng CX, Sen S, LeeSW, Ouchi T. BRCA1 phosphorylation by aurora-a in the regulation of G2 to M transition. J Biol Chem 2004; 279:19643-8.
78. Matsuoka S, Huang M, Elledge SJ. Linkage of ATM to cell cycle regulation by the chk2 protein kinase. Science 1998; 282:1893-7.
79. Martin SA, Ouchi T. BRCA1 phosphorylation regulates caspase-3 activation in UV-induced apoptosis. Cancer Res 2005; 65:10657-62.
80. Riedl SJ, Yigong S. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5:897-907.